ACS Clinical Research Program rss

PACES

PACES trial: Evaluating the effectiveness of eflornithine and sulindac in preventing colon adenomas(Comments Off)

August 1, 2015

The S0820 Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) study seeks to determine whether two drugs that have shown early promise can significantly lower the risk of secondary colorectal polyp or cancer for these survivors.

dispatches-table

Multimodality treatment considerations in esophageal and gastric cancer: Are we making progress?

This column addresses the efficacy of combining existing approaches with active therapeutic combinations to treat cancers of the stomach and esophagus.

OperativeStandardsCover

New manual for cancer surgery issued: Operative Standards for Cancer Surgery

Operative Standards for Cancer Surgery, developed by the ACS Clinical Research Program Cancer Care Standards Development Committee, provides evidence-based guidelines for oncologic resections.

Alliance for Clinical Trials in Oncology

Limited resection as a cure for early lung cancer: Time to challenge the gold standard?

A clinical trial is exploring whether limited resection should replace lobectomy as the gold standard for treatment of early-stage lung cancer.

clinical-res-fig1

Progress in the PROSPECT trial: Precision treatment for rectal cancer?

The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611